Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections.
Kurahashi Y, Sutandhio S, Furukawa K, Tjan LH, Iwata S, Sano S, Tohma Y, Ohkita H, Nakamura S, Nishimura M, Arii J, Kiriu T, Yamamoto M, Nagano T, Nishimura Y, Mori Y. Kurahashi Y, et al. Among authors: tohma y. Front Immunol. 2022 Feb 24;13:773652. doi: 10.3389/fimmu.2022.773652. eCollection 2022. Front Immunol. 2022. PMID: 35281007 Free PMC article.
Cross-Neutralizing Activity Against SARS-CoV-2 Variants in COVID-19 Patients: Comparison of 4 Waves of the Pandemic in Japan.
Furukawa K, Tjan LH, Sutandhio S, Kurahashi Y, Iwata S, Tohma Y, Sano S, Nakamura S, Nishimura M, Arii J, Kiriu T, Yamamoto M, Nagano T, Nishimura Y, Mori Y. Furukawa K, et al. Among authors: tohma y. Open Forum Infect Dis. 2021 Aug 18;8(10):ofab430. doi: 10.1093/ofid/ofab430. eCollection 2021 Oct. Open Forum Infect Dis. 2021. PMID: 34631915 Free PMC article.
Cross-Neutralizing Activity Against Omicron Could Be Obtained in SARS-CoV-2 Convalescent Patients Who Received Two Doses of mRNA Vaccination.
Kurahashi Y, Furukawa K, Sutandhio S, Tjan LH, Iwata S, Sano S, Tohma Y, Ohkita H, Nakamura S, Nishimura M, Arii J, Kiriu T, Yamamoto M, Nagano T, Nishimura Y, Mori Y. Kurahashi Y, et al. Among authors: tohma y. J Infect Dis. 2022 Oct 17;226(8):1391-1395. doi: 10.1093/infdis/jiac178. J Infect Dis. 2022. PMID: 35512332 Free PMC article.
The Neutralizing Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 and the Cytokine/Chemokine Release in Patients with Different Levels of Coronavirus Diseases 2019 Severity: Cytokine Storm Still Persists Despite Viral Disappearance in Critical Patients.
Tjan LH, Nagano T, Furukawa K, Nishimura M, Arii J, Fujinaka S, Iwata S, Sano S, Tohma Y, Nishimura Y, Mori Y. Tjan LH, et al. Among authors: tohma y. JMA J. 2021 Jan 29;4(1):1-7. doi: 10.31662/jmaj.2020-0083. Epub 2021 Jan 14. JMA J. 2021. PMID: 33575497 Free PMC article. Review.
The Number of Coronavirus Disease 2019 Vaccine Doses and Severe Clinical Outcomes in Older Patients Infected With a Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant.
Furukawa K, Kurahashi Y, Ishimaru H, Nishimura M, Arii J, Sano S, Tohma Y, Ohkita H, Nakamura S, Iwata S, Mori Y. Furukawa K, et al. Among authors: tohma y. J Infect Dis. 2022 Nov 28;226(11):2041-2042. doi: 10.1093/infdis/jiac395. J Infect Dis. 2022. PMID: 36161491 Free PMC article. No abstract available.
132 results